Aniket Patel

2504 POSTS
Aniket is a skilled writer at ChatGPT Global News, contributing to the ChatGPT News category. With a passion for exploring the diverse applications of ChatGPT, Aniket brings informative and engaging content to our readers. His articles cover a wide range of topics, showcasing the versatility and impact of ChatGPT in various domains.

Exclusive articles:

Europeans Fear that AI Technology will Take their Jobs Away

Discover the world of Generative AI from a European perspective with the new Euronews Tech Talks podcast. Explore the impact of AI on employment and society with a balanced and informative analysis. Join the discussion on the future of work and society.

ChatGPT: Your Financial Companion for Planning Your Life

Looking to revolutionize your financial planning? Meet ChatGPT - a powerful AI-powered tool that can simplify the process and help you manage your finances effectively. Start today!

Sridhar Vembu Leading Zoho in Developing Rival to ChatGPT for Indian Market

Meet the rival to #ChatGPT - Zoho's AI-powered language model developed by Indian entrepreneur Sridhar Vembu. With a unique adaptive approach, it's set to shake up the industry. #AI #language #modeling

How We Boosted ChatGPT Chatbot’s Speed by 10X

Learn how a company fixed their chatbot's performance issues by deferring reCAPTCHA loading until activation, resulting in a 100% score on PageSpeed Insights. Optimizing website performance is crucial.

Export Your ChatGPT Chat History: Step-by-Step Guide

ChatGPT users can now export their chat history and data with the new feature launched on April 11, 2023. Easily accessible for both free and Plus users, the feature provides valuable insights for personal or professional use. The process is simple, quick, and secure.

Breaking

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.
spot_imgspot_img